Abbvie inc. (ABBV)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12
Cash flows from operating activities
Net earnings

3,010

2,801

1,884

741

2,456

-1,826

2,747

1,983

2,783

52

1,631

1,915

1,711

1,391

1,598

1,610

1,354

1,517

1,239

1,366

1,022

-810

506

1,098

980

1,128

964

1,068

968

1,540

1,585

1,267

883

Adjustments to reconcile net earnings to net cash from operating activities:
Depreciation

115

118

114

114

118

122

115

119

115

101

111

110

103

118

96

108

103

121

102

104

90

97

94

103

89

99

97

100

92

173

93

119

140

Amortization of intangible assets

444

400

427

388

385

326

320

324

330

292

268

269

271

210

208

181

165

140

125

86

68

96

98

99

110

101

137

136

135

136

134

176

179

Change in fair value of contingent consideration liabilities

72

438

180

2,304

169

-383

95

485

-148

79

401

61

85

85

102

41

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation

219

79

75

87

189

70

75

85

191

77

71

76

141

75

69

71

138

53

55

55

119

43

44

48

106

37

42

46

87

31

30

35

91

Upfront costs and milestones related to collaborations

40

149

20

126

195

350

55

555

101

385

32

25

28

50

80

125

25

0

130

23

127

-

-

-

-

-

-

-

-

-

-

-

-

Devaluation loss related to Venezuela

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

298

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquired in-process research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

110

150

Other, net

-1

49

-102

-23

33

347

-305

-17

-101

-157

207

-89

-45

-64

-252

-12

-62

-120

26

-146

-249

-110

-384

13

47

-6

5

-19

-14

-28

-12

-14

-12

Changes in operating assets and liabilities:
Accounts receivable

1,025

-133

111

-220

316

-215

1

124

681

228

-4

133

34

-58

-65

275

-81

234

254

44

544

267

25

47

-167

-27

-69

-528

-57

490

39

-531

-221

Inventories

107

-170

113

160

128

-141

176

120

71

-212

120

70

-71

66

-28

19

-19

-12

286

85

75

223

77

-47

-50

-30

36

61

-11

104

43

49

7

Prepaid expenses and other assets

19

86

-280

-15

112

73

-120

279

267

96

-106

75

53

271

-20

-17

159

-59

-151

40

-341

-40

12

29

219

-422

99

-107

-29

-96

-37

-20

63

Accounts payable and other liabilities

1,065

-539

705

-1,381

94

-691

869

-179

191

-19

974

-264

-266

-212

-1,064

47

42

175

919

221

188

-192

216

395

-612

-653

409

24

-206

-497

440

-662

-12

Cash flows from operating activities

3,815

3,275

4,555

2,477

3,017

3,392

4,524

2,866

2,645

2,584

3,271

2,003

2,102

1,541

1,454

1,918

2,128

1,963

2,155

1,832

1,585

-578

1,786

1,717

624

1,245

1,798

2,037

1,187

941

2,249

1,561

1,594

Cash flows from investing activities
Acquisition of businesses, net of cash acquired

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

10,752

736

-

-

-

-

-

-

-

-

-92

0

109

671

Acquisitions and investments

12

624

36

120

320

195

140

29

372

128

80

37

63

90

40

104

28

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisitions of property and equipment

125

163

154

128

107

123

282

114

119

182

126

126

95

114

113

131

121

145

127

115

145

153

180

142

137

151

133

119

88

95

-18

94

162

Purchases of investment securities

13

4

21

364

194

211

944

370

267

392

447

421

970

795

500

2,678

1,342

-

-

-

-

0

9

500

660

-

-

-

-

-

-

-

-

Sales and maturities of investment securities

26

44

1,589

472

594

246

403

1,200

311

903

544

902

444

780

476

1,070

33

18

872

1

8

-

-

-

-

620

10

500

1,575

523

0

1

629

Other

5

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash flows from investing activities

-129

-615

1,378

-140

-27

-283

-963

687

-447

201

-109

318

-684

-119

-199

-4,298

-1,458

-297

745

-12,511

-873

2,514

-2,284

-359

-797

123

-964

233

1,487

-206

-1,806

-202

-204

Cash flows from financing activities
Net change in commercial paper borrowings

0

0

-306

-193

-200

699

-511

144

-33

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayments of other short-term borrowings

0

0

0

0

3,000

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net change in short-term borrowings

-

-

-

-

-

-

-

-

-

-

-

-

23

-

-494

94

-6

-354

760

-569

144

124

50

248

-410

2

1

-3

-601

-

-

-

-

Repayments of long-term debt and finance lease obligations

-

-

-

-

-

1,014

2,008

3,006

7

7

5

7

6

4,004

1

2,005

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

0

120

59

-

-

-

-

-

-

-

-

-

-

-

-

Dividends paid

1,763

1,595

1,591

1,592

1,588

1,451

1,461

1,531

1,137

1,030

1,026

1,024

1,027

933

933

927

924

840

850

818

786

674

673

673

641

641

640

638

636

-

-

-

-

Purchases of treasury stock

643

2

4

3

620

2,058

1,009

7,516

1,431

505

5

5

895

1,810

6

3,808

409

1,244

998

5,002

342

313

-1

24

329

201

-2

24

97

-

-

-

-

Proceeds from the exercise of stock options

12

2

1

1

4

7

2

2

62

40

65

64

85

58

41

92

77

32

22

54

47

68

37

42

85

103

54

99

91

-

-

-

-

Payments of contingent consideration liabilities

53

43

12

108

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net transactions with Abbott Laboratories, excluding non-cash items

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-20

-55

70

-242

-13,058

2,248

-1,327

-1,367

Other, net

25

-1

15

0

21

-2

11

-32

37

-26

29

-8

26

-35

22

-1

43

-19

9

-20

66

-11

1

-61

18

10

25

-4

-97

-139

-4

1

-9

Cash flows from financing activities

-2,422

26,602

-441

-2,070

-5,383

-3,825

916

-8,978

-2,509

-1,928

-810

-980

-1,794

-2,502

-1,371

1,164

-1,219

-2,431

-1,056

10,169

-930

-882

-719

-415

-1,277

-747

-613

-500

-1,582

2,389

2,244

-1,326

-1,376

Effect of exchange rate changes on cash and equivalents

-46

14

-16

8

1

-10

-9

-35

15

0

6

7

16

-38

7

-13

-294

-59

-21

4

-224

-425

-150

3

-5

-1

11

-6

-14

-

-

-

-

Net change in cash and equivalents

1,218

29,276

5,476

275

-2,392

-726

4,468

-5,460

-296

857

2,358

1,348

-360

-1,118

-109

-1,229

-843

-824

1,823

-506

-442

629

-1,367

946

-1,455

620

232

1,764

1,078

3,140

2,687

33

14